Xcout IntelSign inSubscribe

Oxford Nanopore Technologies competitors & alternatives

BiotechOxford, United Kingdom

The 12 closest competitors and alternatives to Oxford Nanopore Technologies among biotech companies — ranked by similarity to what Oxford Nanopore Technologies actually does, not by market-cap band.

12Competitors listed

Subscribe to see Oxford Nanopore Technologies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products for the direct, electronic analysis of single molecules. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Oxford Nanopore Technologies at a glance

Oxford Nanopore Technologies is a biotech company headquartered in Oxford, United Kingdom, founded in 2005. Xcout tracks 19 named people at Oxford Nanopore Technologies, including Vijay Manthripragada (President, CEO & Director).

Oxford Nanopore Technologies leadership

  • Vijay ManthripragadaPresident, CEO & Director
  • Francis Van ParysChief Executive Officer
  • James LawsChief Operating Officer
  • Allan Michael DicksChief Financial Officer
  • Nick KeherChief Financial Officer
  • Jose RevueltaChief Strategy Officer

13 more named people on record for Oxford Nanopore Technologies, with roles, board committees and tenure — see the full roster →

Top 12 Oxford Nanopore Technologies competitors

Ranked by semantic similarity — how close each company is to Oxford Nanopore Technologies by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

10x Genomics, Inc.TXG · BiotechPleasanton, United States
66% matchPublic

Similar biotech company

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Market cap$9.5B
Employees1,306
10x Genomics, Inc. competitors & alternatives →
Bionano Genomics, Inc.BNGO · BiotechSan Diego, United States
63% matchPublic

Similar biotech company

Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles. The Saphyr platform includes the Saphyr instrument, a device capable of imaging single molecules; the Saphyr Chip, a disposable component equipped with nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide essential reagents and protocols for extracting and tagging ultra-high molecular weight DNA. Furthermore, Bionano Genomics supplies Saphyr and Bionano compute servers to support its analytical operations. It also offers NxClinical, a single software system designed for the analysis and interpretation of genomic variants identified through microarray and next-generation sequencing data, serving both cytogenetics and molecular genetics applications. In addition to its product line, Bionano Genomics delivers a variety of specialized testing and laboratory services. These include: FirstStepDx PLUS: A chromosomal microarray service used to identify underlying genetic causes in individuals with autism spectrum disorder, developmental delay, and intellectual disability. Fragile X syndrome (FXS) testing services: Comprehensive diagnostic testing for FXS. NextStepDx PLUS: An exome sequencing test aimed at detecting genetic variants associated with childhood developmental disorders. EpiPanelDx PLUS: A genetic testing panel for patients experiencing seizures, infantile spasms, encephalopathy, or febrile seizures. PGx test: A pharmacogenomics test that identifies over 60 alleles across 11 genes relevant to drug response. Bionano Genomics was founded in 2003 and operates from its corporate headquarters in San Diego, California.

Market cap$16M
Employees96
Bionano Genomics, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Oxford Nanopore Technologies and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Oxford Nanopore Technologiesand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →